Showing results (1191-1200 of 1,284) with videos related to

Sort By:
Pageof 129
Cancer Epidemiology|July 25, 2016
Common variants in the obesity-associated genes FTO and MC4R are not associated with risk of colorectal cancerBaiyu Yang, Aaron P Thrift, Jane C Figueiredo, et al.
Theranostics|October 14, 2020
First clinical study of a pegylated diabody <sup>124</sup>I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancersAndrew M Scott, Timothy Akhurst, Fook-Thean Lee, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Detection of SARS-CoV-2 Omicron variant (B.1.1.529) infection of white-tailed deerKurt J Vandegrift, Michele Yon, Meera Surendran-Nair, et al.
Communications Biology|August 2, 2024
Empirical and model-based evidence for a negligible role of cattle in peste des petits ruminants virus transmission and eradicationCatherine M Herzog, Fasil Aklilu, Demeke Sibhatu, et al.
Frontiers in Public Health|November 18, 2024
Seroprevalence and risk factors for brucellosis amongst livestock and humans in a multi-herd ranch system in Kagera, TanzaniaBeatus Lyimo, Ephrasia Hugho, Coletha Mathew, et al.
Nature|January 23, 2004
Susceptibility to leprosy is associated with PARK2 and PACRGMarcelo T Mira, Alexandre Alcaïs, Van Thuc Nguyen, et al.
International Journal of Cancer|September 6, 2012
Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trialBen Tran, Andrew M K Brown, Philippe L Bedard, et al.
Microbiology Resource Announcements|December 22, 2023
From Cullowhee Creek to Conley: genome sequence and annotation of a cluster DJ <i>Gordonia</i> phageMindy N Andro, Aj J Cansler, Olivia S Conley, et al.
Science (New York, N.Y.)|June 6, 1998
Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genomeD G Wang, J B Fan, C J Siao, et al.
The Lancet. HIV|October 14, 2021
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority studyHans Jaeger, Edgar T Overton, Gary Richmond, et al.
Pageof 129